Akero Therapeutics shares soar on positive study results By Investing.com

Published on 27 Jan 2025 on Investing.com

Shares of Akero Therapeutics, Inc. (Nasdaq: NASDAQ:AKRO) soared 92% following the release of...

Read the rest of the article

Start tracking your investments with Statfolio

We recently compiled a list of the 5 Stocks That Started The Year On A High. In this article, we ...

Insider Monkey · via Yahoo Finance 3 Feb 2025

We recently compiled a list of the 12 Best Booming Stocks to Invest in Now. In this article, we a...

Insider Monkey · via Yahoo Finance 2 Feb 2025

Yale Catriona, Chief Development Officer at Akero Therapeutics, Inc. (NASDAQ:AKRO), recently sold...

Investing.com 31 Jan 2025

The company remains on track for potential regulatory filings, subject to positive clinical resul...

Zacks · via Yahoo Finance 29 Jan 2025

We recently compiled a list of the 10 Firms Post Impressive Gains on Monday. In this article, we ...

Insider Monkey · via Yahoo Finance 28 Jan 2025

On Monday, Akero Therapeutics, Inc. (NASDAQ:AKRO) released preliminary topline week 96 results fr...

Benzinga · via Yahoo Finance 27 Jan 2025

Shares of Akero Therapeutics, Inc. (Nasdaq: NASDAQ:AKRO) soared 92% following the release of...

Investing.com 27 Jan 2025

Akero Therapeutics Inc (NASDAQ: AKRO) says its candidate treatment for a serious liver disease...

Invezz 27 Jan 2025

We recently compiled a list of the 10 Best Small-Cap Biotech Stocks with Massive Potential Accord...

Insider Monkey · via Yahoo Finance 4 Dec 2024

On September 30, 2024, State Street Corp executed a significant transaction by reducing its holdi...

GuruFocus.com · via Yahoo Finance 17 Oct 2024